Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Fresh Tracks Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(655)
•••
Post by TimeBuilderon Jan 12, 2023 10:13am
349 Views
Post# 35218223

This Rating update copied from TDWBDI ;>))

This Rating update copied from TDWBDI ;>))

Ratings change for Jan. 08, 2023 - Jan. 14, 2023


Date
Symbol
Brokerage
Analyst Name
Analyst Ranking out of 8,244
Current Rating
Current Target
 
11 Jan. 2023
PIPE
National Bank
Dan Payne
3
HOLD
$4.00
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities